Jeremy P. Springhorn Uni Qure N.V. (QURE) insider trading activity

Jeremy P. Springhorn is Director of uniQure N.V.. Currently has a direct ownership of 37,694 shares of QURE, which is worth approximately $2.05 Million. The most recent transaction as insider was on Jun 20, 2025, when has been sold 2,112 shares (Ordinary Shares) at a price of $14.45 per share, resulting in proceeds of $30,518. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 37.7K

0% 3M change

18.4% 12M change

Total Value Held $2.05 Million

Jeremy P. Springhorn Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 20 2025	SELL Open market or private sale	$30,518 $14.45 p/Share	2,112 Reduced 5.31%	37,694 Ordinary Shares
Jun 11 2025	BUY Grant, award, or other acquisition	-	7,970 Added 16.68%	39,806 Ordinary Shares
Jun 19 2024	BUY Grant, award, or other acquisition	-	8,080 Added 20.24%	31,836 Ordinary Shares
Jun 13 2024	SELL Open market or private sale	$11,422 $5.12 p/Share	2,231 Reduced 8.59%	23,756 Ordinary Shares
Jun 16 2023	SELL Open market or private sale	$43,159 $18.88 p/Share	2,286 Reduced 8.09%	25,987 Ordinary Shares
Jun 13 2023	BUY Grant, award, or other acquisition	-	8,700 Added 23.53%	28,273 Ordinary Shares
Feb 27 2023	SELL Open market or private sale	$7,837 $20.41 p/Share	384 Reduced 1.92%	19,573 Ordinary Shares
Jun 15 2022	BUY Grant, award, or other acquisition	-	9,080 Added 31.27%	19,957 Ordinary Shares
Feb 28 2022	SELL Open market or private sale	$10,053 $16.7 p/Share	602 Reduced 5.24%	10,877 Ordinary Shares
Feb 24 2022	BUY Grant, award, or other acquisition	-	1,534 Added 11.79%	11,479 Ordinary Shares
Mar 02 2021	SELL Open market or private sale	$18,938 $37.5 p/Share	505 Reduced 4.83%	9,945 Ordinary Shares
Feb 25 2021	BUY Grant, award, or other acquisition	-	2,382 Added 18.56%	10,450 Ordinary Shares

Also insider at

SYRS

Syros Pharmaceuticals, Inc. Healthcare

Chief Business Officer

JPS